IGF1 and non-small cell lung carcinoma: Epidemiological studies indicate that a high concentration of blood-circulating IGF-1 (endocrine fraction) is a risk factor in numerous types of cancer, including colon cancer (20), prostate cancer (21,22), breast cancer (22) and non-small cell lung cancer (23).